Fresenius Medical Care AG & Co. KGaA
FMCQFOTCHealthcare● Active
$43.01
$-2.16(-4.78%)
Market Cap$11.6B
P/E Ratio—
52W High$58.68
52W Low$42
Fresenius Medical Care AG & Co. KGaA (FMCQF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
FMCQF · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 5, 2026EPS Actual
$1.05
Est. $1.17 · -10.3%
Revenue
$5.33B
Est. $5.32B · +0.1%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 5, 2026
After Market Close
▼ Miss EPS
FMCQF reports quarterly as a OTC-listed Medical - Care Facilities company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.36
Rev. $5.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.36
Rev. Est.$5.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 4, 2026 | $1.21 | — | — | — | $5.45B | — |
| ▼ Q2 FY2026 | May 5, 2026 | $1.17 | $1.05 | -10.3% | $5.33B | $5.32B | +0.1% |
| ▲ Q1 FY2026 | Feb 24, 2026 | $1.33 | $1.69 | +27.1% | $5.95B | $5.69B | +4.7% |
| ▼ Q3 FY2025 | Aug 5, 2025 | $1.03 | $0.90 | -12.2% | $5.64B | $5.00B | +12.9% |
| ▼ Q2 FY2025 | May 6, 2025 | $0.81 | $0.56 | -30.5% | $5.35B | $5.06B | +5.8% |
| ▼ Q1 FY2025 | Feb 25, 2025 | $0.83 | $0.24 | -71.5% | $5.27B | $4.66B | +13.1% |
| ▲ Q4 FY2024 | Nov 5, 2024 | $0.79 | $0.81 | +2.5% | $5.32B | $5.52B | -3.6% |
| ▼ Q3 FY2024 | Jul 30, 2024 | $0.73 | $0.69 | -5.9% | $5.13B | $5.33B | -3.8% |
Q3 FY2026
Aug 4, 2026
EPS Actual
—
EPS Est.
$1.21
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 5, 2026Miss
EPS Actual
$1.05
EPS Est.
$1.17
EPS Surpr.
-10.3%
Revenue
$5.33B
Q1 FY2026
Feb 24, 2026Beat
EPS Actual
$1.69
EPS Est.
$1.33
EPS Surpr.
+27.1%
Revenue
$5.95B
Q3 FY2025
Aug 5, 2025Miss
EPS Actual
$0.90
EPS Est.
$1.03
EPS Surpr.
-12.2%
Revenue
$5.64B
Q2 FY2025
May 6, 2025Miss
EPS Actual
$0.56
EPS Est.
$0.81
EPS Surpr.
-30.5%
Revenue
$5.35B
Q1 FY2025
Feb 25, 2025Miss
EPS Actual
$0.24
EPS Est.
$0.83
EPS Surpr.
-71.5%
Revenue
$5.27B
Q4 FY2024
Nov 5, 2024Beat
EPS Actual
$0.81
EPS Est.
$0.79
EPS Surpr.
+2.5%
Revenue
$5.32B
Q3 FY2024
Jul 30, 2024Miss
EPS Actual
$0.69
EPS Est.
$0.73
EPS Surpr.
-5.9%
Revenue
$5.13B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2027 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2027 | $0.00 | $0.00 | $0.00 | 0 |
| Q1 FY2027 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2026 | $1.16 | $1.18 | $1.21 | 1 |
| Q3 FY2026 | $1.09 | $1.12 | $1.14 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $4.0B | $4.1B | $4.1B | 2 |
| Q3 FY2027 | $6.0B | $6.1B | $6.2B | 2 |
| Q2 FY2027 | $6.0B | $6.1B | $6.2B | 2 |
| Q1 FY2027 | $4.0B | $4.1B | $4.1B | 2 |
| Q4 FY2026 | $5.0B | $5.1B | $5.1B | 2 |
| Q3 FY2026 | $4.9B | $4.9B | $5.0B | 5 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 5, 2026 | -10.3% | $43.08 | $43.08 | +0.00% |
| ▲ Q1 FY2026 | Feb 24, 2026 | +27.1% | $49.21 | $49.21 | +0.00% |
| ▼ Q3 FY2025 | Aug 5, 2025 | -12.2% | $51.06 | $51.06 | +0.00% |
| ▼ Q2 FY2025 | May 6, 2025 | -30.5% | $46.12 | $52.25 | +13.29% |
| ▼ Q1 FY2025 | Feb 25, 2025 | -71.5% | $48.38 | $48.38 | +0.00% |
| ▲ Q4 FY2024 | Nov 5, 2024 | +2.5% | $39.70 | $39.70 | +0.00% |
| ▼ Q3 FY2024 | Jul 30, 2024 | -5.9% | $37.07 | $37.07 | +0.00% |
| ▼ Q2 FY2024 | May 7, 2024 | -56.0% | $41.90 | $41.90 | +0.00% |
Q2 FY2026+0.00%
Report Date
May 5, 2026
EPS Beat/Miss
-10.3%
Price Before
$43.08
Price After
$43.08
Q1 FY2026+0.00%
Report Date
Feb 24, 2026
EPS Beat/Miss
+27.1%
Price Before
$49.21
Price After
$49.21
Q3 FY2025+0.00%
Report Date
Aug 5, 2025
EPS Beat/Miss
-12.2%
Price Before
$51.06
Price After
$51.06
Q2 FY2025+13.29%
Report Date
May 6, 2025
EPS Beat/Miss
-30.5%
Price Before
$46.12
Price After
$52.25
Q1 FY2025+0.00%
Report Date
Feb 25, 2025
EPS Beat/Miss
-71.5%
Price Before
$48.38
Price After
$48.38
Q4 FY2024+0.00%
Report Date
Nov 5, 2024
EPS Beat/Miss
+2.5%
Price Before
$39.70
Price After
$39.70
Q3 FY2024+0.00%
Report Date
Jul 30, 2024
EPS Beat/Miss
-5.9%
Price Before
$37.07
Price After
$37.07
Q2 FY2024+0.00%
Report Date
May 7, 2024
EPS Beat/Miss
-56.0%
Price Before
$41.90
Price After
$41.90
Avg Beat Reaction+0.00%
Avg Miss Reaction+2.21%
Beat Rate2 / 8 quarters
Largest Move+13.29% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: FMCQF ends December
Fresenius Medical Care AG & Co. KGaA (FMCQF) most recently reported earnings on May 5, 2026 for Q2 FY2026, posting EPS of $1.05 — missing the analyst consensus of $1.17 by -10.3%. The next FMCQF earnings date is expected around September 1, 2026.
Each quarter, investors track FMCQF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. FMCQF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
FMCQF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
FMCQF earnings · 5 questionsFresenius Medical Care AG & Co. KGaA's next earnings report is expected around September 1, 2026. FMCQF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; FMCQF historically reports after market close (AMC).
FMCQF earnings datewhen is FMCQF earningsFMCQF next earnings datewhen does FMCQF report earningsFMCQF earnings calendar
▸ Source: FMP · Fresenius Medical Care AG & Co. KGaA SEC filings · US GAAP · Fresenius Medical Care AG & Co. KGaA SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026